Is a complete COYA research report available?

No complete published report is available for Coya Therapeutics, Inc. (COYA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Coya Therapeutics, Inc. (COYA)

NASDAQ: COYA · USD

$4.08

+0.21 (+5.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first COYA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	95.7M
Revenue (ttm)	7.9M
Net income (ttm)	-21.1M
EPS (ttm)	-$1.16
Shares out	23.5M
Volume	151,354
Beta	0.51
Price target	$15.2	+272.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.9M
Net income (ttm): -21.1M
EPS (ttm): -$1.16
Market cap: 95.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All COYA indicators

Market & fundamental data

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001835022
Company name	Coya Therapeutics, Inc.
Country	United States
Country code	US
Cusip	22407B108
Employees	8
Employees Change	2%
Employees Change Percent	33.33
Enterprise value	$45M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2022-12-29
Isin	US22407B1089
Last refreshed	2026-07-31
Market cap	$95.7M
Market cap category	Micro-Cap
Price	$4.08
Price currency	USD
Rev Per Employee	992,377x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	COYA
Website	https://www.coyatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-22.07%
EV Sales Forward	20.85x
EV/Sales	5.67x
FCF yield	-14.75%
P/B ratio	1.95x
P/S ratio	12.06x
PS Forward	44.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-283.64%
EBITDA Margin	-283.35%
Gross margin	-96.71%
Gross Profit	$-7.7M
Net Income	$-21.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-266.07%
Profit Margin	-266.11%
Profit Per Employee	$-2.6M
ROA	-27.57
Roa5y	-40.71
ROCE	-45.29
ROE	-51.31
ROIC	-30.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-36.27%
Cagr3y	0.41%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	115.44x
Revenue Growth Q	-2.61x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.17
Assets	$53.3M
Cash	$50.7M
Current Assets	$53.3M
Current Liabilities	$3.5M
Debt	$0
Equity	$49M
Liabilities	$4.3M
Long Term Assets	$8,420
Long Term Liabilities	$754,198
Net Cash	$50.7M
Net Cash By Market Cap	$53
Net Cash Growth	42.76%
Net Debt Equity	$-1.04
Tangible Book Value	$49M
Tangible Book Value Per Share	$2.09
WACC	7.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	15.02
Net Working Capital	$-1M
Quick ratio	14.3
Working Capital	$49.7M
Working Capital Turnover	$0.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.23%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-36.25%
200-day SMA	5.06
3Y total return	1.24%
50-day SMA	4.87
50-day SMA vs 200-day SMA	50under200
All Time High	10.69
All Time High Change	-61.83%
All Time High Date	2024-03-18
All Time Low	3.21
All Time Low Change	27.1%
All Time Low Date	2023-08-18
ATR	0.31
Beta	0.51
Beta1y	1.33
Beta2y	1.21
Ch YTD	-29.66
High	4.12
High52	7.75
High52 Date	2025-10-14
High52ch	-47.35%
Low	3.92
Low52	3.71
Low52 Date	2026-03-30
Low52ch	9.97%
Ma50ch	-16.19%
Premarket Change Percent	0.78
Premarket Price	$3.9
Premarket Volume	1,455
Price vs 200-day SMA	-19.43%
RSI	35.2
RSI Monthly	44.51
RSI Weekly	41.99
Sharpe ratio	-0.42x
Sortino ratio	-0.53
Total Return	-15.23%
Tr YTD	-29.66
Tr1m	-32.78%
Tr1w	-6.85%
Tr3m	0.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.36
Earnings Revenue Estimate	104,290x
Earnings Revenue Estimate Growth	-36.26x
Operating Income	$-20.2M
Operating margin	-254.7
Price target	$15.21
Price Target Change	$273
Price Target Change Top	$317

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	17,542,806%
Float Percent	74.79%
Shares Insiders	5.57%
Shares Institutions	23.39%
Shares Out	23,457,183
Shares Qo Q	35.25%
Shares Yo Y	15.23%
Short Float	5.98%
Short Ratio	3.88
Short Shares	4.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-19.5M
Adjusted OCF	-19,525,305
Average Volume	259,762.5x
Bv Per Share	2.09
Ch1m	-32.78
Ch1w	-6.85
Ch1y	-36.25
Ch3m	0.25
Ch3y	1.24
Ch6m	-11.3
Change	5.43%
Change From Open	3.55
Close	3.87
Days Gap	1.81
Depreciation Amortization	23,328
Dollar Volume	617,524.3
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-22.5M
EBITDA	$-22.5M
EPS	$-1.16
F Score	4
FCF	$-14.1M
FCF EV Yield	-31.39x
FCF Per Share	$-0.6
Financing CF	31,363,177
Fiscal Year End	December
Founded	2,020
Income Tax	$3,089
Investing CF	-2,049,602
Ipr	-18.4
Iprfo	-14.11
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-16
Ma150	4.71
Ma150ch	-13.38%
Ma20	4.76
Ma20ch	-14.25%
Net CF	15,194,019
Next Earnings Date	2026-08-11
Open	3.94
Optionable	Yes
Position In Range	80
Post Close	4.08
Postmarket Change Percent	-0.25
Postmarket Price	$4.07
Ppne	8,420
Pre Close	3.87
Price Date	2026-07-30
Ptbv Ratio	1.95
Relative Volume	0.58x
Revenue	7,939,016x
SBC By Revenue	68.09x
Share Based Comp	5,405,749
Tax By Revenue	0.04x
Tr6m	-11.3%
Us State	Texas
Volume	151,354
Z Score	13

Coya Therapeutics, Inc. (COYA)

Coverage state: Market snapshot only — no published research

Generate the first COYA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · COYA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All COYA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on COYA

Frequently asked questions